carnosine has been researched along with Disease Exacerbation in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Azarova, OV; Bobrov, IP; Kalnitsky, AS; Makarova, OG; Mazko, ON; Zharikov, AY | 1 |
| Aldini, G; Blasetti Fantauzzi, C; Giaccari, A; Iacobini, C; Lapolla, A; Menini, S; Orioli, M; Pesce, CM; Pugliese, G; Salomone, E | 1 |
| Blasetti Fantauzzi, C; Iacobini, C; Menini, S; Pugliese, G; Ricci, C | 1 |
| Bastawrous, A; Dubois, VD | 1 |
| Ding, Z; Guo, Y; Ha, W; Harding, JJ; Yan, H; Zhang, J | 1 |
| Akiyama, N; Natori, S; Nishigori, H; Sogo, S; Tsujimoto, M; Umeda, IO | 1 |
| Fonteh, AN; Harrington, MG; Harrington, RJ; Liao, P; Tsai, A | 1 |
| Hipkiss, AR | 1 |
2 review(s) available for carnosine and Disease Exacerbation
| Article | Year |
|---|---|
N-acetylcarnosine (NAC) drops for age-related cataract.
Topics: Aged; Aged, 80 and over; Aging; Carnosine; Cataract; Disease Progression; Humans; Middle Aged; Ophthalmic Solutions; Randomized Controlled Trials as Topic | 2017 |
Could carnosine or related structures suppress Alzheimer's disease?
Topics: Age Factors; Alzheimer Disease; Animals; Brain; Carbonic Anhydrases; Carnosine; Cell Death; Cells, Cultured; Disease Progression; Enzyme Activation; Homeostasis; Humans; Reactive Oxygen Species | 2007 |
6 other study(ies) available for carnosine and Disease Exacerbation
| Article | Year |
|---|---|
Effect of Carnosine on the Course of Experimental Urate Nephrolithiasis.
Topics: Animals; Antioxidants; Carnosine; Disease Models, Animal; Disease Progression; Free Radicals; Kidney; Male; Nephrolithiasis; Oxidative Stress; Rats; Rats, Wistar; Uric Acid | 2021 |
FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice.
Topics: Animals; Biological Availability; Carnosine; Cells, Cultured; Diabetic Nephropathies; Dipeptidases; Disease Progression; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Random Allocation | 2018 |
Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice.
Topics: Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biomarkers; Carnosine; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Disease Progression; Female; Glycation End Products, Advanced; Kidney; Mice; Mice, Knockout; Plaque, Atherosclerotic; Signal Transduction; Time Factors | 2015 |
Effect of carnosine, aminoguanidine, and aspirin drops on the prevention of cataracts in diabetic rats.
Topics: Animals; Aspirin; Blood Glucose; Body Weight; Carnosine; Cataract; Cornea; Diabetes Mellitus, Experimental; Disease Progression; Eye Proteins; Glycosylation; Guanidines; Lens, Crystalline; Male; Ophthalmic Solutions; Rats; Rats, Sprague-Dawley; Staining and Labeling; Streptozocin | 2008 |
5-S-GAD, a novel radical scavenging compound, prevents lens opacity development.
Topics: alpha-Crystallins; Animals; Biphenyl Compounds; Carnosine; Cataract; Cells, Cultured; Chick Embryo; Cyclic N-Oxides; Diamide; Dihydroxyphenylalanine; Disease Progression; Dose-Response Relationship, Drug; Free Radical Scavengers; Galactose; Glucocorticoids; Glutathione; Insecta; Lens, Crystalline; Lipid Peroxidation; Male; Oxidative Stress; Picrates; Protein Carbonylation; Rats; Rats, Sprague-Dawley; Spin Labels; Superoxides | 2009 |
Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects.
Topics: Aged; Alzheimer Disease; Amino Acids; Antioxidants; Carnosine; Chromatography, Liquid; Dipeptides; Disease Progression; Female; Histidine; Humans; Male; Middle Aged; Neuropsychological Tests; Spectrometry, Mass, Electrospray Ionization | 2007 |